Effect of suloctidil on rat liver.
The effect of suloctidil (120 mg/kg body weight PO for 3 weeks) on rat liver was investigated using biochemical and morphological methods: enzymatic activities characteristic of the main cellular compartments were used as biochemical markers of hepatocyte function and morphometry was applied to investigate morphological changes. No sign of hepatotoxicity was evidenced after suloctidil treatment (liver weight; cytochrome c oxidase; glucose 6-phosphatase; NADPH-cytochrome c reductase; D-amino acid oxidase; urate oxidase; fatty acid oxidation; peroxisomal number, volume and size distribution). Suloctidil increased catalase activity by 22% without morphologically detectable changes in the peroxisomes. After suloctidil treatment, slightly increased mitochondrial volume fraction and slightly decreased mitochondrial number were noted without significant changes in cytochrome c oxidase. Clofibrate, at the same dose, increased NADPH-cytochrome c reductase, catalase, acylCoA oxidase, mitochondrial and peroxisomal number and volume fraction, and decreased urate oxidase activity.
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000473:pathology*; D002994:Clofibrate / Q000633:toxicity; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008297:Male; D008930:Mitochondria, Liver / Q000201:enzymology; D011412:Propanolamines / Q000633:toxicity*; D051381:Rats; D011919:Rats, Inbred Strains; D013468:Suloctidil / Q000633:toxicity*
D011412:Propanolamines; D002994:Clofibrate; D013468:Suloctidil